LeMaitre Vascular Inc (OQ:LMAT)

Business Focus: Advanced Medical Equipment & Technology

Sector:  Healthcare Industry:  Advanced Medical Equipment & Technology
See Regulatory Filings on SEC
Company Contact
Address: 63 2nd Ave
BURLINGTON MA 01803-4413
Tel: N/A
Website: www.lemaitre.com
IR: See website
Key People
George W. LeMaitre
Chairman of the Board, Chief Executive Officer
Kimberly L. Cieslak
Vice President - Marketing
David Brian Roberts
President, Director
Joseph P. Pellegrino
Chief Financial Officer, Director
Laurie A. Churchill
Senior Vice President, General Counsel
Andrew Hodgkinson
Senior Vice President - Clinical, Regulatory and Quality Affairs
Trent G. Kamke
Senior Vice President - Operations
Stephane Maier
Vice President, EMEA Operations
Giovannella Deiure
Vice President, Sales '€“ Southern Europe
Chance Kriesel
Vice President - Sales, The Americas
Business Overview
LeMaitre Vascular, Inc. is a provider of medical devices for the treatment of peripheral vascular disease. The Company develops, manufactures and markets medical devices and implants used primarily in the field of vascular surgery. It is engaged in the design, marketing, sales and technical support of medical devices and implants for the treatment of peripheral vascular disease industry segment. The Company's product lines include valvulotomes, balloon catheters, carotid shunts, biologic vascular patches, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, prosthetic vascular grafts, biologic vascular grafts and powered phlebectomy devices. Its portfolio of peripheral vascular devices consists of brand name products that are used in arteries and veins outside of the heart, including the Expandable LeMaitre Valvulotome, the Pruitt F3 Carotid Shunt, VascuTape Radiopaque Tape and the XenoSure biologic patch.
Financial Overview
For the nine months ended 30 September 2020,LeMaitre Vascular Inc revenues increased 5% to $91.8M. Netincome increased 7% to $14.2M. Revenues reflect UnitedStates segment increase of 13% to $53.2M, Germany segmentincrease of less than 1% to $9.4M. Net income benefitedfrom Sales and Marketing decrease of 22% to $17.4M(expense), Stock-based Compensation in SGA decrease of 14%to $396K (expense).
Employees: 454 as of Dec 31, 2019
Reporting Currency: U.S. Dollars
Enterprise value: $783.66M as of Sep 30, 2020
Annual revenue (TTM): $121.99M as of Sep 30, 2020
EBITDA (TTM): $31.00M as of Sep 30, 2020
Net annual income (TTM): $18.80M as of Sep 30, 2020
Free cash flow (TTM): $15.62M as of Sep 30, 2020
Net Debt Last Fiscal Year: $25.10M as of Sep 30, 2020
Shares outstanding: 20,341,985 as of Oct 31, 2020
Index Membership: S&P 600 Small Cap
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please subscribe. Our packages start at $1.00 plus tax for the first month.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.